https://doi.org/10.4081/monaldi.2024.2970
Smoking cessation among tuberculosis patients during the coronavirus disease-2019 pandemic
Submitted: February 27, 2024
Accepted: March 25, 2024
Published: April 24, 2024
Accepted: March 25, 2024
Abstract Views: 320
PDF_EARLY VIEW: 155
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Smoking has been recognized as a significant risk factor for COVID-19 and mortality. The World Health Organization (WHO) has recommended smoking cessation to reduce the impact of COVID-19. This study aimed to evaluate the smoking cessation rate of patients starting tuberculosis (TB) treatment at six months using motivational interviewing based on the WHO "five steps to quit" model. In addition, we assessed the knowledge about smoking and the barriers to smoking cessation. We conducted a retrospective cohort study. Outpatients aged >18 years, smokers, and those who are starting TB treatment in two outpatient TB clinics were invited to participate. Patients received information about the importance of smoking cessation, especially in TB patients, and standardized advice based on guidelines. This information was repeated during phone calls during the second and fourth months of treatment. During the study period, 111 patients were included. The primary outcome was the smoking cessation rate at the end of the sixth month of treatment, which was 26.8% (19/71). The barriers to smoking cessation described by the patients were anxiety/depression (47.4%), seeing someone smoking (38.5%), drug use (19.2%), and alcohol abuse (2.6%). The assessment of knowledge about smoking showed that patients had some information gaps. In conclusion, TB smokers who tried to quit smoking during the COVID-19 pandemic faced many challenges. Despite this, we demonstrated a reasonable smoking cessation rate with a nurse-conducted motivational interview.
World Health Organization. Global tuberculosis report 2023. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023.
Lin HH, Ezzati M, Chang HY, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 2009;180:475-80.
DOI: https://doi.org/10.1164/rccm.200904-0549OC
Visser ME, Stead MC, Walzl G, et al. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: Importance of cavities, smoking, time to detection and w-beijing genotype. PLoS One 2012;7:e29588.
DOI: https://doi.org/10.1371/journal.pone.0029588
De Vargas KR, Freitas AA, Azeredo ACV, Silva DR. Smoking prevalence and effects on treatment outcomes in patients with tuberculosis. Rev Assoc Med Bras 2021;67:406-10.
DOI: https://doi.org/10.1590/1806-9282.20200825
Wen CP, Chan TC, Chan HT, et al. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis 2010;10:156.
DOI: https://doi.org/10.1186/1471-2334-10-156
Kıral N, Fidan A, Eraslan B, et al. Effect of the COVID-19 pandemic on smoking habits in a tertiary hospital. Eur Rev Med Pharmacol Sci 2023;27:1170-5.
Zeng Y, Luk TT, Wu Y, et al. Associations of changes in smoking-related practices with quit attempt and smoking consumption during the COVID-19 pandemic: a mixed-methods study. Tob Induc Dis 2022;20:20.
DOI: https://doi.org/10.18332/tid/156454
Finck JM, Bohnet S, Auth K, et al. Smoking behavior and smoking cessation because of and during the COVID-19 pandemic: a brief online survey 12 months into the pandemic and during the second wave in Europe. Int J Environ Res Public Health 2022;19:16540.
DOI: https://doi.org/10.3390/ijerph192416540
World Health Organization. The importance of tobacco cessation in the context of the COVID-19 pandemic. 2021. Available from: https://www.who.int/news-room/events/detail/2021/03/16/default-calendar/the-importance-of-tobacco-cessation-in-the-context-of-the-COVID-19-pandemic. Accessed on: 24/03/2023.
World Health Organization. Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care. 2014. Available from: https://iris.who.int/bitstream/handle/10665/112835/9789241506953_eng.pdf?sequence=1&isAllowed=y. Accessed on: 24/03/2023.
Ministério da Saúde. Boletim epidemiológico tuberculose. 2022. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2022/boletim-epidemiologico-de-tuberculose-numero-especial-marco-2022.pdf. [Material in Portuguese].
Silva DR, Rabahi MF, Sant'Anna CC, et al. Diagnosis of tuberculosis: a consensus statement from the Brazilian Thoracic Association. J Bras Pneumol 2021;47:e202210054.
Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 1989;12:159-82.
DOI: https://doi.org/10.1007/BF00846549
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991;86:1119-27.
DOI: https://doi.org/10.1111/j.1360-0443.1991.tb01879.x
Richmond RL, Kehoe LA, Webster IW. Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction 1993;88:1127-35.
DOI: https://doi.org/10.1111/j.1360-0443.1993.tb02132.x
Louwagie GMC, Ayo-Yusuf OA. Predictors of tobacco smoking abstinence among tuberculosis patients in South Africa. J Behav Med 2015;38:472-82.
DOI: https://doi.org/10.1007/s10865-015-9620-y
Jeyashree K, Nayak P. TB and tobacco integration: what is missing and what can we expect?. Int J Tuberc Lung Dis 2018;22:711.
DOI: https://doi.org/10.5588/ijtld.18.0353
Ng N, Padmawati RS, Prabandari YS, Nichter M. Smoking behavior among former tuberculosis patients in Indonesia: intervention is needed. Int J Tuberc Lung Dis 2008;12:567-72.
Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;2013:CD000165.
DOI: https://doi.org/10.1002/14651858.CD000165.pub4
Demers RY, Neale AV, Adams R, et al. The impact of physicians’ brief smoking cessation counseling: a MIRNET study. J Fam Pract 1990;31:625-9.
Perski O, Theodoraki M, Cox S, et al. Associations between smoking to relieve stress, motivation to stop and quit attempts across the social spectrum: a population survey in England. PLoS One 2022;17:e0268447.
DOI: https://doi.org/10.1371/journal.pone.0268447
Giovenco DP, Spillane TE, Maggi RM, et al. Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: a qualitative study in the United States. Int J Drug Policy 2021;94:103175.
DOI: https://doi.org/10.1016/j.drugpo.2021.103175
Grogan S, Walker L, McChesney G, et al. How has COVID-19 lockdown impacted smoking? A thematic analysis of written accounts from UK smokers. Psychol Health 2022;37:17-33.
DOI: https://doi.org/10.1080/08870446.2020.1862110
O’donnell R, Eadie D, Stead M, et al. ‘I was smoking a lot more during lockdown because I can’: a qualitative study of how UK smokers responded to the covid-19 lockdown. Int J Environ Res Public Health 2021;18:5816.
DOI: https://doi.org/10.3390/ijerph18115816
Neubert C, Nussbaum AK, Tewes N, Westwood P. Barriers to quitting smoking – a survey among 1000 adult cigarette smokers in Germany. Qeios 2022.
DOI: https://doi.org/10.32388/N507Y2.3
West JC, Peasley-Miklus C, Graham AL, et al. Impact of alcohol and drug use on smoking and cessation in socioeconomically disadvantaged young adults. Addict Behav 2020;110:106486.
DOI: https://doi.org/10.1016/j.addbeh.2020.106486
Cheng HG, McBride O, Phillips MR. Relationship between knowledge about the harms of smoking and smoking status in the 2010 Global Adult Tobacco China Survey. Tob Control 2015;24:54-61.
DOI: https://doi.org/10.1136/tobaccocontrol-2013-051163
Snell LM, Colby SM, Deatley T, et al. associations between nicotine knowledge and smoking cessation behaviors among US adults who smoke. Nicotine Tob Res 2022;24:855-63.
DOI: https://doi.org/10.1093/ntr/ntab246
Ethics Approval
The study was approved by the Ethics Committee of Hospital de Clínicas de Porto Alegre in June 3rd, 2020 (number 180540).How to Cite
Coutinho, Sandra Eugênia, Raimunda Sinthia Lima de Braga, André Külzer Santos, Joanna Scopel Velho, and Denise Rossato Silva. 2024. “Smoking Cessation Among Tuberculosis Patients During the Coronavirus Disease-2019 Pandemic”. Monaldi Archives for Chest Disease, April. https://doi.org/10.4081/monaldi.2024.2970.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Giuliana Cimino, Enrico Vizzardi, Emiliano Calvi, Edoardo Pancaldi, Greta Pascariello, Nicola Bernardi, Angelica Cersosimo, Ludovica Amore, Riccardo M. Inciardi, Riccardo Raddino, Marco Metra, Endothelial dysfunction in COVID-19 patients assessed with Endo-PAT2000 , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Rahul Tyagi, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Pawan Tiwari, Randeep Guleria, Assessment of the impact and reorganization of interventional pulmonology services at a tertiary care centre during nationwide lockdown for COVID-19 pandemic , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu, Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova? , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Barun Kumar, Ashwin Kodliwadmath, Amar Upadhyay, Anupam Singh, Nanda N, Apparently normal epicardial coronaries in a patient with inferior wall myocardial infarction on the background of mild coronavirus disease-2019: take a second look! , Monaldi Archives for Chest Disease: Vol. 91 No. 3 (2021)
- Giorgio E. Polistina, Francesca Simioli, Pasquale Imitazione, Maurizia Lanza, Anna Annunziata, Giuseppe Fiorentino, Different presentation of pulmonary parenchymal disruption in COVID-19 pneumonia. Case series of Sub-Intensive Care Unit in Naples, Italy , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Christos Michailides, Dimitrios Velissaris, Common anti-oxidant vitamin C as an anti-infective agent with remedial role on SARS-CoV-2 infection. An update , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Mohd Mustahsin, Sanjay Choubey, Garima Singh, Madhulika Dubey, Sachin Khanduri, Rachit Sharma, Amit Srivastava, COVID-19 pneumonia in kyphoscoliosis: The success stories , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Tobin P. Mangel, Brendan P. Madden, Acute tracheal tear – A potential cause of spontaneous pneumomediastinum in patients with COVID-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Nitish Aggarwal, Tarun Krishna Boppana, Saurabh Mittal, COVID-19 pandemic: The testing times for healthcare workers , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Aravind Gandhi Periyasamy, Soundappan Kathirvel, Tanveer Rehman, Amarjeet Singh, Demographic and clinical factors associated with early hospital Coronovirus disease 2019 deaths in a low middle income setting: A record-based analysis of 20,641 deaths from India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
You may also start an advanced similarity search for this article.
